UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



FORM 6-K


REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE MONTH OF MAY 2021


COMMISSION FILE NUMBER 001-38976

Genmab A/S
(Exact name of Registrant as specified in its charter)

Kalvebod Brygge 43

1560 Copenhagen V

Denmark

+45 70 20 27 28
(Address of principal executive offices)


Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F  Form 40-F 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)

Yes  No 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)

Yes  No 

This report on Form 6-K shall be deemed to be incorporated by reference in Genmab A/S’s registration statements on Form S-8 (File No. 333-232693) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

nthony

GENMAB A/S

BY:

/s/ Anthony Pagano

Name: Anthony Pagano

Title: Executive Vice President & Chief Financial Officer

DATE: May 25, 2021


EXHIBIT INDEX

O

Exhibit

Description of Exhibit

99.1

Company Announcement Dated May 25, 2021: Transactions in connection with share buy-back program

99.1(a)

Appendix: Transactions May 17-21, 2021


Exhibit 99.1

Graphic

Transactions in connection with share buy-back program

Company Announcement

COPENHAGEN, Denmark; May 25, 2021 – Genmab A/S (Nasdaq: GMAB). On February 23, 2021 Genmab announced the initiation of a share buy-back program to mitigate dilution from warrant exercises and to honor our commitments under our Restricted Stock Units program.

The share buy-back program is expected to be completed no later than June 30, 2021 and comprises up to 200,000 shares.

The following transactions were executed under the program from May 17, 2021 to May 21, 2021:

 

No. of shares

Average price (DKK)

Total value (DKK)

Accumulated through last announcement

141,100

 

296,339,455

May 17, 2021

600

2,322.74

1,393,644

May 18, 2021

1,000

2,329.26

2,329,260

May 19, 2021

May 20, 2021

1,200

2,000

2,304.19

2,333.25

2,765,028

4,666,500

May 21, 2021

1,900

2,380.34

4,522,646

Total

6,700

15,677,078

Accumulated under the program

147,800

 

312,016,533

Details of each transaction are included as an appendix to this announcement.

Following these transactions, Genmab holds 247,006 shares as treasury shares, corresponding to 0.38% of the total share capital and voting rights.

The share buy-back program is undertaken in accordance with Regulation (EU) No. 596/2014 (‘MAR’) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the “Safe Harbour Regulation.” Further details on the terms of the share buy-back program can be found in our company announcement no. 11 dated February 23, 2021.

About Genmab

Genmab is an international biotechnology company with a core purpose to improve the lives of patients with cancer. Founded in 1999, Genmab is the creator of multiple approved antibody therapeutics that are marketed by its partners. The company aims to create, develop and commercialize differentiated therapies by leveraging next-generation antibody technologies, expertise in antibody biology, translational research and data sciences and strategic partnerships. To create novel therapies, Genmab utilizes its next-generation antibody technologies, which are the result of its collaborative company culture and a deep passion for innovation. Genmab’s proprietary pipeline consists of modified antibody candidates, including bispecific T-cell engagers and next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. The company is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan. For more information, please visit Genmab.com.

Genmab A/S

Tel: +45 7020 2728

Company Announcement no. 46

Kalvebod Brygge 43

Fax: +45 7020 2729

Page 1/2

21560 Copenhagen V, Denmark

www.genmab.com

CVR no. 2102 3884

LEI Code 529900MTJPDPE4MHJ122


Graphic

Transactions in connection with share buy-back program

Contact:
Marisol Peron, Senior Vice President, Global Investor Relations & Communications

T: +1 609 524 0065; E: mmp@genmab.com

For Investor Relations:

Andrew Carlsen, Vice President, Head of Investor Relations

T: +45 3377 9558; E: acn@genmab.com


This Company Announcement contains forward looking statements. The words “believe”, “expect”, “anticipate”, “intend” and “plan” and similar expressions identify forward looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our actual results or performance to differ materially include, among others, risks associated with pre-clinical and clinical development of products, uncertainties related to the outcome and conduct of clinical trials including unforeseen safety issues, uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products or technologies obsolete, and other factors. For a further discussion of these risks, please refer to the risk management sections in Genmab’s most recent financial reports, which are available on www.genmab.com and the risk factors included in Genmab’s most recent Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange Commission (SEC), which are available at www.sec.gov. Genmab does not undertake any obligation to update or revise forward looking statements in this Company Announcement nor to confirm such statements to reflect subsequent events or circumstances after the date made or in relation to actual results, unless required by law.


Genmab A/S and/or its subsidiaries own the following trademarks: Genmab®; the Y-shaped Genmab logo®; Genmab in combination with the Y-shaped Genmab logo®; HuMax®; DuoBody®; DuoBody in combination with the DuoBody logo®; HexaBody®; HexaBody in combination with the HexaBody logo®; DuoHexaBody® and HexElect®.

Genmab A/S

Tel: +45 7020 2728

Company Announcement no. 46

Kalvebod Brygge 43

Fax: +45 7020 2729

Page 2/2

21560 Copenhagen V, Denmark

www.genmab.com

CVR no. 2102 3884

LEI Code 529900MTJPDPE4MHJ122


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 17-21, 2021

Graphic

Volume

Price

Venue

Time CET

29

2360

XCSE

20210521 9:01:17.354000

25

2361

XCSE

20210521 9:03:56.680000

21

2358

XCSE

20210521 9:06:09.318000

34

2358

XCSE

20210521 9:09:33.884000

26

2363

XCSE

20210521 9:13:00.922000

21

2363

XCSE

20210521 9:16:18.413000

5

2363

XCSE

20210521 9:20:40.791000

16

2363

XCSE

20210521 9:20:40.810000

10

2359

XCSE

20210521 9:23:38.119000

8

2359

XCSE

20210521 9:23:38.119000

19

2356

XCSE

20210521 9:27:16.304000

18

2356

XCSE

20210521 9:32:08.976000

42

2360

XCSE

20210521 9:42:30.381000

2

2360

XCSE

20210521 9:42:30.381000

19

2369

XCSE

20210521 9:47:58.216000

18

2368

XCSE

20210521 9:52:45.086000

29

2376

XCSE

20210521 10:00:15.795000

19

2373

XCSE

20210521 10:05:42.905000

18

2370

XCSE

20210521 10:10:57.338000

19

2370

XCSE

20210521 10:18:56.044000

18

2365

XCSE

20210521 10:23:27.443000

18

2366

XCSE

20210521 10:28:05.599000

19

2368

XCSE

20210521 10:34:08.023000

19

2364

XCSE

20210521 10:40:12.312000

21

2364

XCSE

20210521 10:48:29.089000

25

2369

XCSE

20210521 10:58:28.591000

44

2375

XCSE

20210521 11:15:54.289000

2

2375

XCSE

20210521 11:15:54.289000

18

2375

XCSE

20210521 11:25:21.738000

18

2377

XCSE

20210521 11:32:22.008000

26

2379

XCSE

20210521 11:44:25.805000

1

2384

XCSE

20210521 11:55:00.413000

20

2385

XCSE

20210521 11:56:22.594000

18

2381

XCSE

20210521 12:07:15.330000

18

2379

XCSE

20210521 12:16:45.409000

1

2375

XCSE

20210521 12:26:00.532000

8

2375

XCSE

20210521 12:26:23.785000

18

2376

XCSE

20210521 12:29:34.322000

19

2374

XCSE

20210521 12:40:28.876000

1


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 17-21, 2021

Graphic

18

2375

XCSE

20210521 12:46:27.579000

21

2379

XCSE

20210521 12:56:30.179000

8

2383

XCSE

20210521 13:05:39.642000

13

2383

XCSE

20210521 13:06:02.527000

22

2384

XCSE

20210521 13:16:38.747000

28

2386

XCSE

20210521 13:31:05.864000

18

2386

XCSE

20210521 13:39:57.587000

18

2384

XCSE

20210521 13:48:23.976000

18

2383

XCSE

20210521 13:57:39.099000

18

2384

XCSE

20210521 14:04:28.286000

42

2387

XCSE

20210521 14:20:02.437000

22

2387

XCSE

20210521 14:29:05.376000

1

2389

XCSE

20210521 14:41:26.550000

20

2392

XCSE

20210521 14:48:24.419000

5

2392

XCSE

20210521 14:48:24.419000

20

2392

XCSE

20210521 14:48:24.419000

18

2389

XCSE

20210521 14:52:06.350000

18

2388

XCSE

20210521 14:59:25.465000

24

2392

XCSE

20210521 15:07:39.936000

18

2392

XCSE

20210521 15:07:39.936000

19

2392

XCSE

20210521 15:08:56.053671

1

2392

XCSE

20210521 15:08:56.053671

20

2392

XCSE

20210521 15:08:56.053671

60

2392

XCSE

20210521 15:09:08.061252

18

2390

XCSE

20210521 15:16:51.075000

18

2390

XCSE

20210521 15:17:07.193000

19

2390

XCSE

20210521 15:20:08.804000

18

2390

XCSE

20210521 15:20:08.804000

18

2390

XCSE

20210521 15:22:02.666000

19

2390

XCSE

20210521 15:24:33.683000

19

2392

XCSE

20210521 15:27:41.008000

9

2392

XCSE

20210521 15:27:41.008000

9

2392

XCSE

20210521 15:28:00.185000

2

2388

XCSE

20210521 15:29:57.306000

15

2388

XCSE

20210521 15:30:01.525000

1

2388

XCSE

20210521 15:30:03.044000

19

2388

XCSE

20210521 15:32:25.007000

9

2388

XCSE

20210521 15:32:55.128000

2

2390

XCSE

20210521 15:35:15.894000

17

2390

XCSE

20210521 15:35:15.894000

2


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 17-21, 2021

Graphic

19

2389

XCSE

20210521 15:37:52.560000

11

2389

XCSE

20210521 15:38:07.901000

7

2389

XCSE

20210521 15:38:13.173000

18

2388

XCSE

20210521 15:39:58.400000

18

2384

XCSE

20210521 15:41:53.183000

3

2384

XCSE

20210521 15:45:08.329000

15

2384

XCSE

20210521 15:45:16.040000

19

2383

XCSE

20210521 15:46:02.009000

17

2386

XCSE

20210521 15:55:46.205000

31

2386

XCSE

20210521 15:55:46.205000

30

2386

XCSE

20210521 15:55:46.205000

29

2392

XCSE

20210521 16:00:52.512000

18

2392

XCSE

20210521 16:00:52.512000

20

2392

XCSE

20210521 16:04:20.494000

19

2392

XCSE

20210521 16:07:33.468000

19

2391

XCSE

20210521 16:08:57.551000

19

2393

XCSE

20210521 16:12:46.890000

18

2393

XCSE

20210521 16:12:46.890000

18

2393

XCSE

20210521 16:15:51.797000

17

2390

XCSE

20210521 16:20:04.706000

4

2390

XCSE

20210521 16:20:04.706000

19

2388

XCSE

20210521 16:22:59.911000

19

2385

XCSE

20210521 16:29:14.186000

18

2384

XCSE

20210521 16:29:25.692000

64

2383

XCSE

20210521 16:31:03.027842

37

2328

XCSE

20210520 9:00:58.148000

9

2315

XCSE

20210520 9:04:20.396000

13

2315

XCSE

20210520 9:04:20.414000

9

2312

XCSE

20210520 9:05:44.886000

10

2312

XCSE

20210520 9:05:44.886000

19

2305

XCSE

20210520 9:07:46.512000

18

2311

XCSE

20210520 9:10:33.113000

19

2309

XCSE

20210520 9:11:12.684000

20

2317

XCSE

20210520 9:13:55.207000

4

2317

XCSE

20210520 9:19:45.543000

24

2317

XCSE

20210520 9:19:45.543000

18

2312

XCSE

20210520 9:23:06.745000

22

2314

XCSE

20210520 9:28:59.117000

18

2319

XCSE

20210520 9:31:48.988000

18

2318

XCSE

20210520 9:37:06.243000

3


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 17-21, 2021

Graphic

19

2316

XCSE

20210520 9:40:28.433000

5

2313

XCSE

20210520 9:46:20.732000

7

2313

XCSE

20210520 9:46:46.750000

7

2313

XCSE

20210520 9:46:47.503000

10

2321

XCSE

20210520 9:52:46.848000

17

2321

XCSE

20210520 9:52:46.848000

33

2325

XCSE

20210520 10:03:10.840000

2

2331

XCSE

20210520 10:06:41.655000

1

2331

XCSE

20210520 10:07:01.886000

16

2331

XCSE

20210520 10:07:02.080000

22

2337

XCSE

20210520 10:15:28.421000

19

2332

XCSE

20210520 10:20:29.626000

18

2330

XCSE

20210520 10:25:50.336000

23

2330

XCSE

20210520 10:32:03.109000

18

2323

XCSE

20210520 10:38:03.059000

19

2331

XCSE

20210520 10:45:03.128000

18

2327

XCSE

20210520 10:51:15.733000

20

2325

XCSE

20210520 11:00:18.935000

18

2321

XCSE

20210520 11:09:32.572000

24

2322

XCSE

20210520 11:16:37.024000

22

2320

XCSE

20210520 11:26:26.540000

1

2320

XCSE

20210520 11:26:30.679000

21

2322

XCSE

20210520 11:37:22.424000

29

2323

XCSE

20210520 11:50:10.361000

15

2324

XCSE

20210520 12:05:36.674000

10

2324

XCSE

20210520 12:06:03.620000

21

2324

XCSE

20210520 12:16:19.717000

5

2325

XCSE

20210520 12:24:48.908000

4

2325

XCSE

20210520 12:24:59.780000

5

2325

XCSE

20210520 12:25:05.603000

35

2327

XCSE

20210520 12:39:27.708000

19

2330

XCSE

20210520 12:50:38.985000

21

2334

XCSE

20210520 13:03:00.661000

13

2332

XCSE

20210520 13:07:12.044000

5

2332

XCSE

20210520 13:07:12.044000

18

2333

XCSE

20210520 13:19:39.719000

18

2329

XCSE

20210520 13:29:11.084000

18

2329

XCSE

20210520 13:35:43.448000

18

2334

XCSE

20210520 13:44:10.652000

1

2335

XCSE

20210520 13:51:14.793000

4


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 17-21, 2021

Graphic

32

2335

XCSE

20210520 13:57:30.644000

18

2335

XCSE

20210520 14:04:05.297000

3

2335

XCSE

20210520 14:06:25.497000

3

2335

XCSE

20210520 14:06:25.514000

12

2335

XCSE

20210520 14:07:03.474000

18

2332

XCSE

20210520 14:12:37.257000

27

2334

XCSE

20210520 14:29:59.998000

30

2334

XCSE

20210520 14:29:59.998000

2

2336

XCSE

20210520 14:35:02.280000

22

2336

XCSE

20210520 14:35:02.280000

18

2336

XCSE

20210520 14:35:02.280000

18

2335

XCSE

20210520 14:42:35.176000

18

2335

XCSE

20210520 14:42:35.176000

18

2333

XCSE

20210520 14:48:15.533000

18

2332

XCSE

20210520 14:55:24.957000

13

2332

XCSE

20210520 14:57:10.872000

5

2332

XCSE

20210520 14:57:10.872000

9

2328

XCSE

20210520 15:07:55.339000

9

2328

XCSE

20210520 15:07:55.339000

18

2328

XCSE

20210520 15:07:55.339000

19

2325

XCSE

20210520 15:12:00.325000

46

2325

XCSE

20210520 15:22:42.307000

23

2325

XCSE

20210520 15:22:42.307000

22

2324

XCSE

20210520 15:25:20.361000

19

2324

XCSE

20210520 15:25:20.361000

8

2323

XCSE

20210520 15:27:10.907000

7

2323

XCSE

20210520 15:27:10.907000

3

2323

XCSE

20210520 15:27:11.386000

19

2323

XCSE

20210520 15:29:39.830000

19

2323

XCSE

20210520 15:29:39.830000

18

2327

XCSE

20210520 15:31:01.074000

20

2332

XCSE

20210520 15:32:21.905000

3

2333

XCSE

20210520 15:35:46.038000

22

2333

XCSE

20210520 15:35:46.038000

24

2337

XCSE

20210520 15:38:06.970000

25

2340

XCSE

20210520 15:42:53.220000

16

2344

XCSE

20210520 15:47:54.728000

4

2344

XCSE

20210520 15:47:54.728000

4

2344

XCSE

20210520 15:47:54.728000

10

2344

XCSE

20210520 15:47:54.728000

5


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 17-21, 2021

Graphic

22

2345

XCSE

20210520 15:48:57.658000

19

2345

XCSE

20210520 15:48:57.658000

19

2348

XCSE

20210520 15:53:27.353000

25

2348

XCSE

20210520 15:54:34.160000

18

2344

XCSE

20210520 15:57:53.712000

19

2342

XCSE

20210520 15:59:59.081000

29

2352

XCSE

20210520 16:03:15.966000

18

2351

XCSE

20210520 16:04:58.946000

21

2358

XCSE

20210520 16:08:33.590000

26

2358

XCSE

20210520 16:08:33.590000

26

2358

XCSE

20210520 16:08:33.590000

21

2358

XCSE

20210520 16:08:46.550000

19

2358

XCSE

20210520 16:11:17.055000

19

2357

XCSE

20210520 16:12:26.307000

19

2354

XCSE

20210520 16:15:13.455000

18

2354

XCSE

20210520 16:15:27.875000

25

2357

XCSE

20210520 16:25:25.680000

24

2357

XCSE

20210520 16:25:25.680000

18

2357

XCSE

20210520 16:33:26.426000

9

2357

XCSE

20210520 16:35:37.468000

9

2357

XCSE

20210520 16:35:37.468000

7

2357

XCSE

20210520 16:36:13.223686

4

2357

XCSE

20210520 16:36:13.223686

30

2357

XCSE

20210520 16:36:13.223686

21

2357

XCSE

20210520 16:36:13.288745

19

2300

XCSE

20210519 9:00:10.000000

18

2292

XCSE

20210519 9:02:55.272000

18

2297

XCSE

20210519 9:09:18.870000

20

2297

XCSE

20210519 9:09:18.870000

19

2300

XCSE

20210519 9:12:00.873000

19

2309

XCSE

20210519 9:17:08.982000

18

2304

XCSE

20210519 9:23:26.752000

1

2307

XCSE

20210519 9:29:13.462000

19

2307

XCSE

20210519 9:29:52.274000

18

2300

XCSE

20210519 9:35:08.241000

19

2299

XCSE

20210519 9:42:46.146000

20

2307

XCSE

20210519 9:50:05.146000

18

2303

XCSE

20210519 9:58:28.198000

21

2305

XCSE

20210519 10:05:09.188000

20

2307

XCSE

20210519 10:14:49.289000

6


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 17-21, 2021

Graphic

21

2309

XCSE

20210519 10:24:18.168000

19

2310

XCSE

20210519 10:33:12.743000

23

2315

XCSE

20210519 10:43:46.835000

24

2320

XCSE

20210519 10:56:54.205000

18

2321

XCSE

20210519 11:08:06.622000

21

2324

XCSE

20210519 11:21:21.307000

5

2322

XCSE

20210519 11:35:04.057000

18

2325

XCSE

20210519 11:38:40.793000

18

2322

XCSE

20210519 11:48:52.889000

24

2321

XCSE

20210519 12:09:32.082000

8

2325

XCSE

20210519 12:23:10.602000

10

2325

XCSE

20210519 12:23:10.623000

22

2322

XCSE

20210519 12:40:55.554000

18

2322

XCSE

20210519 12:53:34.262000

18

2315

XCSE

20210519 13:07:00.181000

18

2311

XCSE

20210519 13:20:24.385000

19

2303

XCSE

20210519 13:36:02.959000

50

2300

XCSE

20210519 13:39:08.921992

18

2297

XCSE

20210519 13:51:04.606000

18

2295

XCSE

20210519 14:03:04.235000

18

2297

XCSE

20210519 14:14:05.586000

18

2297

XCSE

20210519 14:23:28.208000

10

2297

XCSE

20210519 14:33:29.352000

8

2297

XCSE

20210519 14:33:29.352000

18

2301

XCSE

20210519 14:45:40.859000

18

2300

XCSE

20210519 14:57:15.415000

18

2301

XCSE

20210519 15:08:03.071000

19

2298

XCSE

20210519 15:17:42.262000

19

2296

XCSE

20210519 15:20:15.319000

28

2299

XCSE

20210519 15:29:52.195000

16

2299

XCSE

20210519 15:29:52.195000

11

2299

XCSE

20210519 15:34:17.676000

8

2299

XCSE

20210519 15:34:17.676000

19

2293

XCSE

20210519 15:40:05.867000

6

2296

XCSE

20210519 15:45:12.002000

12

2296

XCSE

20210519 15:45:12.002000

1

2298

XCSE

20210519 15:51:39.049000

15

2299

XCSE

20210519 15:52:44.051000

7

2299

XCSE

20210519 15:52:44.051000

16

2298

XCSE

20210519 15:54:33.314000

7


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 17-21, 2021

Graphic

18

2299

XCSE

20210519 15:58:50.377000

18

2298

XCSE

20210519 16:01:12.092000

8

2294

XCSE

20210519 16:02:43.983000

10

2294

XCSE

20210519 16:02:43.983000

19

2293

XCSE

20210519 16:07:14.203000

22

2292

XCSE

20210519 16:10:12.475000

18

2298

XCSE

20210519 16:14:51.962000

18

2298

XCSE

20210519 16:14:51.962000

1

2297

XCSE

20210519 16:20:44.464000

17

2297

XCSE

20210519 16:20:44.464000

18

2301

XCSE

20210519 16:24:40.607000

18

2304

XCSE

20210519 16:27:28.403000

3

2304

XCSE

20210519 16:28:01.898522

10

2304

XCSE

20210519 16:28:01.898544

2

2304

XCSE

20210519 16:28:01.898546

10

2304

XCSE

20210519 16:28:01.898546

4

2304

XCSE

20210519 16:28:01.898565

15

2304

XCSE

20210519 16:28:01.898654

11

2304

XCSE

20210519 16:28:02.849457

2

2304

XCSE

20210519 16:28:03.557960

14

2304

XCSE

20210519 16:28:19.180047

2

2304

XCSE

20210519 16:28:19.180047

1

2350

XCSE

20210518 9:01:03.168000

19

2346

XCSE

20210518 9:01:16.623000

18

2339

XCSE

20210518 13:49:51.604000

18

2339

XCSE

20210518 14:17:30.004000

18

2338

XCSE

20210518 14:03:31.098000

20

2337

XCSE

20210518 16:13:31.397000

15

2337

XCSE

20210518 16:13:31.397000

6

2336

XCSE

20210518 14:33:25.337000

17

2336

XCSE

20210518 14:33:39.034000

18

2336

XCSE

20210518 16:24:45.574000

12

2334

XCSE

20210518 16:36:48.235000

19

2333

XCSE

20210518 15:24:43.271000

19

2332

XCSE

20210518 14:49:29.680000

21

2332

XCSE

20210518 15:07:10.584000

33

2332

XCSE

20210518 15:20:01.706000

11

2332

XCSE

20210518 15:20:01.706000

4

2332

XCSE

20210518 15:29:15.025000

14

2332

XCSE

20210518 15:30:01.608000

8


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 17-21, 2021

Graphic

18

2331

XCSE

20210518 13:32:37.949000

21

2331

XCSE

20210518 15:36:45.695000

15

2331

XCSE

20210518 15:36:45.695000

5

2331

XCSE

20210518 16:06:06.487000

18

2331

XCSE

20210518 16:06:06.487000

21

2330

XCSE

20210518 11:17:25.914000

18

2330

XCSE

20210518 12:30:12.160000

12

2330

BEUP

20210518 14:44:54.616186

101

2330

BEUP

20210518 14:44:54.616186

1

2330

XCSE

20210518 14:47:27.881000

18

2330

XCSE

20210518 16:40:26.517000

7

2330

XCSE

20210518 16:44:18.062000

5

2330

XCSE

20210518 16:44:19.614000

12

2329.5

MCSE

20210518 14:44:54.528634

19

2329

XCSE

20210518 9:08:37.486000

23

2329

XCSE

20210518 9:21:39.290000

27

2329

XCSE

20210518 12:56:06.023000

18

2328

XCSE

20210518 9:28:05.710000

18

2328

XCSE

20210518 13:13:48.280000

19

2328

XCSE

20210518 15:43:47.516000

19

2328

XCSE

20210518 15:56:48.088000

14

2328

XCSE

20210518 15:56:48.088000

2

2328

XCSE

20210518 15:56:48.088000

19

2327

XCSE

20210518 9:13:35.459000

18

2327

XCSE

20210518 9:36:29.868000

18

2327

XCSE

20210518 11:32:34.544000

19

2327

XCSE

20210518 12:16:05.944000

18

2327

XCSE

20210518 15:49:25.397000

18

2326

XCSE

20210518 9:05:02.218000

23

2326

XCSE

20210518 11:53:53.749000

18

2325

XCSE

20210518 9:44:53.389000

21

2324

XCSE

20210518 11:02:07.789000

19

2320

XCSE

20210518 10:04:45.579000

13

2318

XCSE

20210518 10:25:46.414000

6

2318

XCSE

20210518 10:25:46.414000

19

2317

XCSE

20210518 10:14:22.603000

20

2317

XCSE

20210518 10:47:42.570000

19

2316

XCSE

20210518 9:54:34.954000

18

2313

XCSE

20210518 10:34:01.243000

200

2290.62

XCSE

20210517 11:34:41.590356

9


Exhibit 99.1(a)

APPENDIX Share buy-back programme - Specification for May 17-21, 2021

Graphic

1

2308

XCSE

20210517 11:36:45.928000

18

2304

XCSE

20210517 11:52:44.477000

18

2309

XCSE

20210517 12:14:08.024000

19

2310

XCSE

20210517 12:35:01.985000

19

2321

XCSE

20210517 12:56:38.275000

20

2320

XCSE

20210517 13:17:01.014000

19

2321

XCSE

20210517 13:36:52.215000

21

2330

XCSE

20210517 13:58:31.020000

20

2324

XCSE

20210517 14:16:36.225000

18

2322

XCSE

20210517 14:31:47.211000

18

2338

XCSE

20210517 14:51:09.496000

18

2340

XCSE

20210517 15:07:05.355000

18

2343

XCSE

20210517 15:19:09.138000

18

2341

XCSE

20210517 15:22:49.710000

2

2339

XCSE

20210517 15:28:01.129000

16

2339

XCSE

20210517 15:28:01.129000

10

2350

XCSE

20210517 15:34:59.867000

18

2359

XCSE

20210517 15:38:33.798000

19

2359

XCSE

20210517 15:47:33.975000

1

2362

XCSE

20210517 15:53:06.319000

16

2365

XCSE

20210517 15:54:21.019000

19

2371

XCSE

20210517 15:55:23.325000

18

2372

XCSE

20210517 15:57:54.072000

1

2366

XCSE

20210517 16:02:22.369000

7

2360

XCSE

20210517 16:09:07.901000

7

2363

XCSE

20210517 16:16:34.982000

10

2367

XCSE

20210517 16:25:57.022847

10

2367

XCSE

20210517 16:25:57.195232

1

2367

XCSE

20210517 16:25:59.956249

10